← FDA DRUG APPROVALS

FDA ANDA · ANDA091676

OXYTOCIN

Sponsor: SAGENT PHARMS INC

APPLICATION
ANDA091676
TYPE
ANDA
ORIGINAL APPROVAL
2018-07-13
LATEST ACTION
2018-07-13
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

OXYTOCINPrescription
OXYTOCIN 10USP UNITS/ML (10USP UNITS/ML) · INJECTABLE · INJECTION
OXYTOCINPrescription
OXYTOCIN 100USP UNITS/10ML (10USP UNITS/ML) · INJECTABLE · INJECTION

Approval history

2018-07-13Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →